Postoperative complications following mastopexy and reduction mammaplasty in patients with cannabis use disorder: a propensity-matched cohort study
JPRAS Open · 2026-11 · 52 · 138-145
DOI: 10.1016/j.jpra.2026.08.016 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JPRAS Open, 2026-11. Verfasst von Neil Upreti und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Stanford University, Stanford, CA, United States. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Cannabis use disorder (CUD) is increasingly prevalent among surgical patients, yet its association with postoperative complications following breast surgery remains poorly characterized. This study compared rates of surgical site complications and emergency department (ED) utilization after mastopexy and reduction mammaplasty between patients with and without documented CUD.
Methods
A retrospective, propensity-matched cohort study was performed using the TriNetX federated research network. Patients undergoing mastopexy or reduction mammaplasty with documented CUD within 3 years before surgery (cannabis cohort) were matched 1:1 to patients without CUD (control cohort) on age, sex, race, ethnicity, comorbidities, and procedure type. Patients with cocaine or methamphetamine use were excluded from both cohorts. Primary outcomes included 90-day rates of surgical site infection (SSI), wound dehiscence, and seroma or hematoma, as well as 30-day ED visits. Risk ratios (RRs) with 95% confidence intervals (CIs) were calculated.
Results
Among 2444 matched patients (1222 per group), CUD was associated with higher rates of surgical site infection (3.8%vs 2.0%; RR, 1.84; P = 0.011), seroma or hematoma (3.6%vs 2.0%; RR, 1.83; P = 0.014), and 30-day ED visits (14.2%vs 9.6%; RR, 1.48; P < 0.001). Wound dehiscence rates did not differ significantly (5.6%vs 4.2%; RR, 1.35; P = 0.092). Causal attribution of outcomes to the index procedure could not be established.
Conclusions
CUD was associated with modestly increased rates of wound complications and ED utilization following mastopexy and reduction mammaplasty. While absolute risk differences were small, these findings may inform preoperative counseling and postoperative monitoring in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Stanford University, Stanford, CA, United States.
- Department of Plastic Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Department of Orthopedic Surgery, Baylor University Medical Center, Dallas, TX, United States.
Zitieren
APA
Upreti, N., Chilappa, R., Tummala, S., & Nagarkar, P. (2026). Postoperative complications following mastopexy and reduction mammaplasty in patients with cannabis use disorder: a propensity-matched cohort study. JPRAS Open, 52, 138-145. https://doi.org/10.1016/j.jpra.2026.08.016
Vancouver
Upreti N, Chilappa R, Tummala S, Nagarkar P. Postoperative complications following mastopexy and reduction mammaplasty in patients with cannabis use disorder: a propensity-matched cohort study. JPRAS Open. 2026;52:138-145. doi:10.1016/j.jpra.2026.08.016
BibTeX
@article{Upreti2026,
author = {Upreti, Neil and Chilappa, Rishi and Tummala, Sri and Nagarkar, Purushottam},
title = {Postoperative complications following mastopexy and reduction mammaplasty in patients with cannabis use disorder: a propensity-matched cohort study},
journal = {JPRAS Open},
year = {2026},
volume = {52},
pages = {138--145},
doi = {10.1016/j.jpra.2026.08.016}
}
EUVIMED